Endo Gets OK For $27M Deal With Novavax In Contract Fight
A New York bankruptcy judge on Wednesday gave Endo International permission to settle a contract dispute with COVID-19 vaccine maker Novavax for $27 million after the pharmaceutical company said Novavax may...To view the full article, register now.
Already a subscriber? Click here to view full article